Strontium Ranelate: The First Dual Action Bone Agent
No abstract available.
| Published in: | South African Family Practice |
|---|---|
| Main Author: | R. Chunder |
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2006-07-01
|
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/620 |
Similar Items
Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
by: Olga Borisovna Yershova
Published: (2010-12-01)
by: Olga Borisovna Yershova
Published: (2010-12-01)
STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01)
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01)
Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01)
by: Kurtuluş Kaya, et al.
Published: (2009-12-01)
POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01)
by: N. J. Hozjainova, et al.
Published: (2016-01-01)
Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
by: N V Toroptsova, et al.
Published: (2008-06-01)
by: N V Toroptsova, et al.
Published: (2008-06-01)
Strontium ranelate enriched Ruminococcus albus in the gut microbiome of Sprague–Dawley rats with postmenopausal osteoporosis
by: Xiao Xiao, et al.
Published: (2023-11-01)
by: Xiao Xiao, et al.
Published: (2023-11-01)
Comparison of the Effects of Strontium Ranelate and Raloxiphene on Bone Mineral Density in Postmenopausal Osteoporosis - Original Investigation
by: Figen Yılmaz, et al.
Published: (2009-04-01)
by: Figen Yılmaz, et al.
Published: (2009-04-01)
THE PLACE OF STRONTIUM RANELATE IN THE TREATMENT OF PATIENTS WITH OSTEOPOROSIS (RESULTS OF THE MARC PROGRAM)
by: O. A. Nikitinskaya, et al.
Published: (2018-09-01)
by: O. A. Nikitinskaya, et al.
Published: (2018-09-01)
Strontium ranelate is a drug to treat osteoarthrosis
by: Oksana Anatolyevna Nikitinskaya
Published: (2013-03-01)
by: Oksana Anatolyevna Nikitinskaya
Published: (2013-03-01)
Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis
by: Kássya Mycaela Paulino Silva, et al.
Published: (2021-04-01)
by: Kássya Mycaela Paulino Silva, et al.
Published: (2021-04-01)
The Comparison of the Effect of Risedronate and Strontium Ranelate on Bone Mineral Density in Postmenopausal Women
by: Figen Yılmaz, et al.
Published: (2012-08-01)
by: Figen Yılmaz, et al.
Published: (2012-08-01)
STRONTIUM RANELATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: IMPACT OF VITAMIN D RECEPTOR AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 GENE POLYMORPHISMS ON BONE MINERAL DENSITY: A PILOT STUDY
by: M. Yu. Krylov, et al.
Published: (2017-07-01)
by: M. Yu. Krylov, et al.
Published: (2017-07-01)
Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis
by: T.A. Rodrigues, et al.
by: T.A. Rodrigues, et al.
The Short-Term Effects of Strontium Ranelate on Pain and Bone Mineral Density in Postmenopausal Women with Osteoporosis
by: Halil Koyuncu, et al.
Published: (2012-08-01)
by: Halil Koyuncu, et al.
Published: (2012-08-01)
PATHOGENESIS OF OSTEOARTHRITIS AND SUBSTANTIATION OF THE USE OF STRONTIUM RANELATE
by: Elena Mikhailovna Zaitseva, et al.
Published: (2014-02-01)
by: Elena Mikhailovna Zaitseva, et al.
Published: (2014-02-01)
Effect of Strontium Ranelate on Condylar Growth during Mandibular Advancement in Rats
by: Hasan Camcı, et al.
Published: (2020-12-01)
by: Hasan Camcı, et al.
Published: (2020-12-01)
Strontium ranelate retards disc degradation and improves endplate and bone micro-architecture in ovariectomized rats with lumbar fusion induced – Adjacent segment disc degeneration
by: Qi Sun, et al.
Published: (2024-03-01)
by: Qi Sun, et al.
Published: (2024-03-01)
Effect of strontium ranelate and cerium oxide addition in the diet on egg production and eggshell quality in laying hen
by: PAYAM SADQ SABIR, et al.
Published: (2023-01-01)
by: PAYAM SADQ SABIR, et al.
Published: (2023-01-01)
Reversed phase HPLC for strontium ranelate: Method development and validation applying experimental design
by: Kovács Béla, et al.
Published: (2018-06-01)
by: Kovács Béla, et al.
Published: (2018-06-01)
Strontium ranelate inhibits wear particle-induced aseptic loosening in mice
by: Tianxiang Geng, et al.
Published: (2018-07-01)
by: Tianxiang Geng, et al.
Published: (2018-07-01)
Evaluation of Biocompatibility of New Osteoplastic Xenomaterials Containing Zoledronic Acid and Strontium Ranelate
by: Maksim V. Stogov, et al.
Published: (2023-06-01)
by: Maksim V. Stogov, et al.
Published: (2023-06-01)
Strontium Ranelate Inhibits Osteoclastogenesis through NF-κB-Pathway-Dependent Autophagy
by: Dongle Wu, et al.
Published: (2023-03-01)
by: Dongle Wu, et al.
Published: (2023-03-01)
Osteogenesis capability of three-dimensionally printed poly(lactic acid)-halloysite nanotube scaffolds containing strontium ranelate
by: Boraei Seyyed Behnam Abdollahi, et al.
Published: (2022-05-01)
by: Boraei Seyyed Behnam Abdollahi, et al.
Published: (2022-05-01)
Clinical and radiographic diagnostic study of strontium ranelate andmetal-substituted hydroxyapatite bone graft materials in diabetesmellitus with chronic periodontitis
by: Omar Khashaba, et al.
Published: (2020-12-01)
by: Omar Khashaba, et al.
Published: (2020-12-01)
Osteoinductivity and Antibacterial Properties of Strontium Ranelate-Loaded Poly(Lactic-co-Glycolic Acid) Microspheres With Assembled Silver and Hydroxyapatite Nanoparticles
by: Zhenyang Mao, et al.
Published: (2018-04-01)
by: Zhenyang Mao, et al.
Published: (2018-04-01)
STUDY OF ENDOTHELIAL PROTECTIVE AND OSTEOPROTECTIVE PROPERTIES OF ROSUVASTATIN, L-NORVALINE AND THEIR COMBINATIONS IN EXPERIMENTAL OSTEOPOROSIS
by: M. S. SOBOLEV, et al.
Published: (2017-12-01)
by: M. S. SOBOLEV, et al.
Published: (2017-12-01)
Repurposing the Strontium Ranelate Antiosteoporotic Drug as a New Outstanding Biocompatible Blue Dye
by: Luca M. Sihn, et al.
Published: (2023-09-01)
by: Luca M. Sihn, et al.
Published: (2023-09-01)
Strontium and Osteoporosis
by: Ferda Özdemir, et al.
Published: (2004-06-01)
by: Ferda Özdemir, et al.
Published: (2004-06-01)
Comparative pharmacoeconomic analysis of the use of Bonviva® (ibandronat) to prevent fractures in postmenopausal osteoporosis
by: E A Pyadushkina, et al.
Published: (2012-12-01)
by: E A Pyadushkina, et al.
Published: (2012-12-01)
Advanced applications of strontium-containing biomaterials in bone tissue engineering
by: Xiao Sheng, et al.
Published: (2023-06-01)
by: Xiao Sheng, et al.
Published: (2023-06-01)
Apatite/Chitosan Composites Formed by Cold Sintering for Drug Delivery and Bone Tissue Engineering Applications
by: Anna Galotta, et al.
Published: (2024-02-01)
by: Anna Galotta, et al.
Published: (2024-02-01)
Mineral density and chemical composition of the rats’ mandibles in experimental models of generalized periodontitis
by: L.M. Matvieienko
Published: (2022-06-01)
by: L.M. Matvieienko
Published: (2022-06-01)
Evaluation of osteogenic properties of a novel injectable bone-repair material containing strontium in vitro and in vivo
by: Lishuang Liu, et al.
Published: (2024-04-01)
by: Lishuang Liu, et al.
Published: (2024-04-01)
Research progress of strontium and pregnancy and pregnancy diseases
by: WANG Rui, LI Rui, LI Yunlong, ZHANG Yuping, YU Kang, LIU Yanping
Published: (2024-04-01)
by: WANG Rui, LI Rui, LI Yunlong, ZHANG Yuping, YU Kang, LIU Yanping
Published: (2024-04-01)
Injectable hyaluronic acid/nanohydroxyapatite composite hydrogels for localized drug delivery and bone repair
by: A. Rubina, et al.
Published: (2025-12-01)
by: A. Rubina, et al.
Published: (2025-12-01)
High proportion strontium-doped micro-arc oxidation coatings enhance early osseointegration of titanium in osteoporosis by anti-oxidative stress pathway
by: Xinkun Shen, et al.
Published: (2022-04-01)
by: Xinkun Shen, et al.
Published: (2022-04-01)
The role of bone anabolic drugs in the management of periodontitis: a scoping review
by: G Cecoro, et al.
Published: (2021-03-01)
by: G Cecoro, et al.
Published: (2021-03-01)
Strontium-loaded multifunctional gelatin methacryloyl hydrogels for type-H vascularized bone regeneration under osteoporotic conditions
by: Yuwei He, et al.
Published: (2025-06-01)
by: Yuwei He, et al.
Published: (2025-06-01)
Estimation of Some Biomarkers Related to Bone Turnover in Iraqi Women
by: Wafaa Raji Alfatlawi
Published: (2025-04-01)
by: Wafaa Raji Alfatlawi
Published: (2025-04-01)
Effects of tibolone on markers of bone metabolic activity in postmenopausal women
by: Marić-Krejović Snežana, et al.
Published: (2012-01-01)
by: Marić-Krejović Snežana, et al.
Published: (2012-01-01)
Similar Items
-
Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
by: Olga Borisovna Yershova
Published: (2010-12-01) -
STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01) -
Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01) -
POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01) -
Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
by: N V Toroptsova, et al.
Published: (2008-06-01)
